✦ LIBER ✦

6082 Second-line treatments in patients with metastatic colorectal cancer progressed after first-line FOLFOXIRI

✍ Scribed by Masi, G.; Vasile, E.; Loupakis, F.; Fornaro, L.; Salvatore, L.; Cupini, S.; Stasi, I.; Brunetti, I.M.; Andreuccetti, M.; Falcone, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6080 Reintroduction of FOLFOXIRI treatme

✍ Vasile, E.; Masi, G.; Loupakis, F.; Cupini, S.; Baldi, G.G.; Salvatore, L.; Forn 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

FOLFOXIRI plus bevacizumab as first-line

✍ Loupakis, F.; Cremolini, C.; Salvatore, L.; Masi, G.; Sensi, E.; Schirripa, M.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 651 KB

Second-Line Treatment of Patients With M

✍ Philippe Rougier; Celine Lepere 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 244 KB

Metastatic Colorectal Cancer: First- and

✍ Philippe Rougier; Céline Lepère 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 201 KB

First-Line Treatment Strategies for Elde

✍ Dr Hielke J. Meulenbeld, Geert-Jan Creemers 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 158 KB

Capecitabine maintenance therapy after f

✍ Yan Li; Jing Li; Ming Lu; Xi-cheng Wang; Lin Shen 📂 Article 📅 2010 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 198 KB